223 related articles for article (PubMed ID: 17826047)
1. Bioavailability and bioequivalence of topical glucocorticoids.
Wiedersberg S; Leopold CS; Guy RH
Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
Wiedersberg S; Naik A; Leopold CS; Guy RH
Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
[TBL] [Abstract][Full Text] [Related]
3. Clinical microdialysis in skin and soft tissues: an update.
Schmidt S; Banks R; Kumar V; Rand KH; Derendorf H
J Clin Pharmacol; 2008 Mar; 48(3):351-64. PubMed ID: 18285620
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inequivalence of pharmaceutical alternates.
Levy RA
Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084
[No Abstract] [Full Text] [Related]
5. Topical glucocorticosteroids.
Fritz KA; Weston WL
Ann Allergy; 1983 Feb; 50(2):68-76. PubMed ID: 6337530
[TBL] [Abstract][Full Text] [Related]
6. Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel.
Tettey-Amlalo RN; Kanfer I; Skinner MF; Benfeldt E; Verbeeck RK
Eur J Pharm Sci; 2009 Feb; 36(2-3):219-25. PubMed ID: 18848881
[TBL] [Abstract][Full Text] [Related]
7. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects.
Au WL; Skinner MF; Benfeldt E; Verbeeck RK; Kanfer I
Skin Pharmacol Physiol; 2012; 25(1):17-24. PubMed ID: 21860254
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticosteroid treatment of asthma.
Bai TR
Can Fam Physician; 1995 Nov; 41():1921-7. PubMed ID: 8563509
[TBL] [Abstract][Full Text] [Related]
10. Topical corticosteroids: a review of properties and principles in therapeutic use.
Chaffman MO
Nurse Pract Forum; 1999 Jun; 10(2):95-105. PubMed ID: 10542586
[TBL] [Abstract][Full Text] [Related]
11. Topical glucocorticoids: what has been achieved? What is still to be done?
Schäfer-Korting M
Curr Probl Dermatol; 1993; 21():192-201. PubMed ID: 8299373
[No Abstract] [Full Text] [Related]
12. [Local therapy with corticoids].
Schalla W
Z Hautkr; 1985 Apr; 60(7):609-18. PubMed ID: 4002771
[No Abstract] [Full Text] [Related]
13. Influence of formulation factors on the availability of drugs from topical preparations.
Asche H; Botta L; Rettig H; Weirich EG
Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
[TBL] [Abstract][Full Text] [Related]
15. Generic topical corticosteroids.
Med Lett Drugs Ther; 1988 May; 30(765):49-50. PubMed ID: 3362092
[No Abstract] [Full Text] [Related]
16. The skin-blanching assay.
Smit P; Neumann HA; Thio HB
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1197-202. PubMed ID: 22303935
[TBL] [Abstract][Full Text] [Related]
17. Striving for standards in bioequivalence assessment: a review.
Schulz HU; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S1-6. PubMed ID: 1601528
[No Abstract] [Full Text] [Related]
18. Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid.
Vooturi S; Bourne D; Panda JJ; Choi S; Kim H; Yandrapu SK; Kompella UB
J Ocul Pharmacol Ther; 2020; 36(6):404-409. PubMed ID: 32678687
[No Abstract] [Full Text] [Related]
19. Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations.
Borsadia S; Ghanem AH; Seta Y; Higuchi WI; Flynn GL; Behl CR; Shah VP
Skin Pharmacol; 1992; 5(3):129-45. PubMed ID: 1445703
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid therapy-induced skin atrophy.
Schoepe S; Schäcke H; May E; Asadullah K
Exp Dermatol; 2006 Jun; 15(6):406-20. PubMed ID: 16689857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
